Method for producing molecularly imprinted polymer nanoparticles, molecularly imprinted polymer nanoparticle, component and device

The emulsion polymerization method addresses the inefficiencies of existing nanoparticle production by creating smaller, high-affinity molecularly imprinted polymer nanoparticles through controlled template release, enhancing target interaction and sensitivity.

WO2026235199A1PCT designated stage Publication Date: 2026-11-12OKINAWA INST OF SCI & TECH SCHOOL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2026/017687
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-08
Filing Date
2026-05-08
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing methods for producing molecularly imprinted polymer nanoparticles are laborious, yield relatively large-sized nanoparticles with low affinity for the target, and result in inefficient binding.

Method used

A method involving emulsion polymerization of functional and stimulus-responsive monomers with a crosslinker in the presence of a template material, followed by stimulus-induced release of the template to form molecularly imprinted polymer nanoparticles with controlled size and high affinity.

Benefits of technology

The method produces molecularly imprinted polymer nanoparticles with a smaller size and enhanced affinity for the target, improving interaction and sensitivity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2026017687_12112026_PF_FP_ABST
    Figure JP2026017687_12112026_PF_FP_ABST
Patent Text Reader

Abstract

To provide an inexpensive method of producing molecularly imprinted polymer nanoparticles with a smaller size and high affinity for a selected target. A method for producing molecularly imprinted polymer nanoparticles, comprising: subjecting a functional monomer, a stimulus-responsive monomer, and a crosslinker to an emulsion polymerization process in the presence of a template material and optionally an initiator; and releasing the template material from a reaction product of the emulsion polymerization process by applying a corresponding stimulus to the stimulus-responsive monomer to obtain the molecularly imprinted polymer nanoparticles.
Need to check novelty before this filing date? Find Prior Art

Description

METHOD FOR PRODUCING MOLECULARLY IMPRINTED POLYMER NANOPARTICLES, MOLECULARLY IMPRINTED POLYMER NANOPARTICLE, COMPONENT AND DEVICE

[0001] The present disclosure relates to a method for producing molecularly imprinted polymer nanoparticles, a molecularly imprinted polymer nanoparticle, a component and a device.Background

[0002] The concept of molecular imprinting, where a polymer is created to "remember" or "recognize" a specific molecule (called the template), was first proposed by Wulff (1972) and Klotz (1973). They aimed to create synthetic polymers that could mimic the selective binding properties of biological macromolecules (e.g., antibodies, enzymes). The idea is to use a template molecule that interacts with monomers (the building blocks of the polymer), forming a stable complex. After polymerization, the template is removed, leaving behind a cavity in the polymer that specifically binds to the original template molecule or similar molecules.

[0003] One of the recent studies of a molecularly imprinted polymer (hereinafter also referred to as “MIP”) is a method of producing MIP nanoparticles by suspension polymerization. PTL 1 discloses a surface-hydrophilic molecularly imprinted polymer microsphere produced using suspension polymerization.

[0004] Other studies include a solid-phase polymerization as disclosed in PTL 2 and NPTL 1. This method comprises immobilizing a template molecule onto a solid support, and then building the polymer around the template molecule.

[0005] Further, NPTL 2 discloses a rapid microwaveable suspension polymerization technique to produce MIP nanoparticles from methacrylic acid (MAA) as the functional monomer and ethylene glycol dimethacrylate (EGDMA) as a suitable cross-linker.

[0006] PTL 1: CN102059104A PTL 2: US101899934B2

[0007] NPTL 1: Mark V. Sullivan, et al. “polymer nanoparticle-based surface plasmon resonance sensor platform for antibiotic detection in river water and milk”, Analytical and Bioanalytical Chemistry, Volume 414, pages 3687-3696, (2022) NPTL 2: Mark V. Sullivan et al, “A rapid synthesis of molecularly imprinted polymer nanoparticles for the extraction of performance enhancing drugs (PIEDs)”, Nanoscale Adv., 2023, 5, 5352-5360 .Summary

[0008] All the methods of producing MIP nanoparticles disclosed in the above prior art references involve a laborious process, and produce a relatively low yield of nanoparticles with relatively large size, and with a lower affinity for a selected target.

[0009] An object of the present disclosure is to provide an inexpensive method of producing molecularly imprinted polymer nanoparticles with a smaller size and high affinity for a selected target.

[0010] The gist of the present disclosure is as follows: [1] A method for producing molecularly imprinted polymer nanoparticles, comprising: subjecting a functional monomer, a stimulus-responsive monomer, and a crosslinker to an emulsion polymerization process in the presence of a template material and optionally an initiator; and releasing the template material from a reaction product of the emulsion polymerization process by applying a corresponding stimulus to the stimulus-responsive monomer to obtain the molecularly imprinted polymer nanoparticles. [2] The method for producing molecularly imprinted polymer nanoparticles according to [1], wherein the emulsion polymerization process includes mixing and stirring a premixed mixture containing the template material, the functional monomer, the stimulus-responsive monomer and a hydrophobic organic solvent; an aqueous solution containing an aqueous solvent and optionally an emulsifier; the crosslinker; and optionally the initiator. [3] The method for producing molecularly imprinted polymer nanoparticles according to [1] or [2], wherein the functional monomer is capable of interacting with the template material by hydrogen bonding, metal coordination, hydrophobic forces, van der Waals forces, or electrostatic forces. [4] The method for producing molecularly imprinted polymer nanoparticles according to any one of [1] to [3], wherein the functional monomer is selected from the group consisting of a (meth)acrylate, a (meth)acrylamide, an amine compound, an alcohol compound, a phenolic compound, a carboxylic acid compound, a imidazole compound, a thiol compound, a pyrrole compound, a pyridine compound, an isocyanate compound, a cyanate compound, an isocyanurate compound, a boronic acid compound, a nucleoside, and a carbohydrate. [5] The method for producing molecularly imprinted polymer nanoparticles according to any one of [1] to [4], wherein the stimulus-responsive monomer is responsive to temperature, pH, light, ionic strength, electric field, magnetic field or the presence of a specific chemical species. [6] The method for producing molecularly imprinted polymer nanoparticles according to any one of [1] to [5], wherein the stimulus-responsive monomer is a temperature-responsive monomer selected from the group consisting of N-isopropylacrylamide (NiPAm), polyethylene glycol methacrylate (PEGMA), 2-(dimethylamino)ethyl methacrylate (DMAEMA), and triethylene glycol dimethacrylate (TEGMA). [7] The method for producing molecularly imprinted polymer nanoparticles according to any one of [1] to [6], wherein the crosslinker is selected from the group consisting of 1,2-ethanediol di(meth)acrylate, 1,3-propanediol di(meth)acrylate, 1,3-butanediol di(meth)acrylate, 1,4-butanediol di(meth)acrylate, 1,5-pentanediol di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, ethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, butylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, polypropylene glycol di(meth)acrylate, polybutylene glycol di(meth)acrylate, allyl (meth)acrylate, divinylbenzene, trivinylbenzene, and trialkylisocyanurate. [8] The method for producing molecularly imprinted polymer nanoparticles according to any one of [1] to [7], wherein the amount of the crosslinker is 2 mol or more, and 10 mol or less, per total of one mol of the functional monomer and the stimulus-responsive monomer. [9] The method for producing molecularly imprinted polymer nanoparticles according to any one of [1] to [8], further comprising subjecting a monomer having a labeling function to the emulsion polymerization process.

[0010] The method for producing molecularly imprinted polymer nanoparticles according to [9], wherein the labeling function is based on a fluorescent label, a colorimetric label, an electrochemical label, a magnetic label, a quantum dot or nanoparticle-based label, an optical sensor label, a photoacoustic label, a biological label or an enzyme-linked label.

[0011] The method for producing molecularly imprinted polymer nanoparticles according to any one of [1] to

[0010] , wherein the template material is selected from the group consisting of biological receptor, nucleic acid, cell, spore, virus, microorganism, tissue sample, carbohydrate, oligosaccharide, polysaccharide, peptide, nucleoprotein, mucoprotein, lipoprotein, synthetic protein, glycoprotein, glycosaminoglycan, steroid, hormone, immunosuppressant, heparin, antibiotic, vitamin, biomarker of a pathological or disease state, toxin, pesticide, herbicide, explosive, nerve agent, pollutant, endocrine disrupting compound, nucleotide, nucleoside, oligonucleotide, metabolite, secondary metabolite, drug metabolite, drug intermediate and drug.

[0012] A molecularly imprinted polymer nanoparticle, wherein the nanoparticle has an average particle size determined by dynamic light scattering of 60 nm or less.

[0013] The molecularly imprinted polymer nanoparticle according to

[0012] , wherein the nanoparticle has an average particle size of 40 nm or more and 60 nm or less.

[0014] The molecularly imprinted polymer nanoparticle according to

[0012] or

[0013] , wherein the ratio of nanoparticles with a diameter of 40 nm to less than 60 nm is more than 90%.

[0015] The molecularly imprinted polymer nanoparticle according to any one of

[0012] to

[0014] , wherein the nanoparticle comprises a copolymer of a functional monomer, a stimulus-responsive monomer, a cross-linker and optionally a monomer having a labeling function, and has at least one cavity corresponding to a template material

[0016] A component comprising a plurality of molecularly imprinted polymer nanoparticles according to any one of

[0012] to

[0015] immobilized on a carrier.

[0017] The component according to

[0016] , wherein the carrier has a functional group on its surface and the plurality of molecularly imprinted polymer nanoparticles is immobilized on the carrier by forming a covalent bond between the functional group and a functional group of a unit derived from the functional monomer of the copolymer.

[0018] A device comprising the component according to claim

[0016] or

[0017] .

[0011] According to the present disclosure, an inexpensive method of producing molecularly imprinted polymer nanoparticles with a smaller size and high affinity for a selected target is provided.

[0012] In the accompanying drawings: FIG.1: Fig.1 is a schematic diagram of the present method. FIG 2: Fig.2 is a sensor performance against target molecule Cortisol and non-target Cholesterol in the application example. FIG 3: Fig.3 shows a chart regarding the cumulative distribution of the MIP nanoparticles obtained in Example 1.DETAILED DESCRIPTION

[0013] The presently disclosed techniques will be described in detail below.

[0014] 1. A method for producing molecularly imprinted polymer nanoparticles The present disclosure relates to a method for producing molecularly imprinted polymer (hereinafter also referred to as “MIP”) nanoparticles, comprising: subjecting a functional monomer, a stimulus-responsive monomer, and a crosslinker to an emulsion polymerization process in the presence of a template material and optionally an initiator; and releasing the template material from a reaction product of the emulsion polymerization process by applying a corresponding stimulus to the stimulus-responsive monomer to obtain the molecularly imprinted polymer nanoparticles.

[0015] According to the present method, the functional monomer, the stimulus monomer and the crosslinker are mixed with the template material to form a complex, and they are crosslinked together to form a polymer. Then, the template material is removed to leave behind a cavity within each of the polymer nanoparticles that is specific in shape, size and electrostatically specific to the template material. Figure 1 shows a schematic diagram of the method.

[0016] The present method employs emulsion polymerization, where polymerization takes place in solution. It is assumed that the template material is surrounded by the monomers in various directions, resulting in the formation of cavities of various shapes in a single MIP nanoparticle after the template material is removed. Therefore, it is expected that the target molecule (original template material) will be precisely bound to the MIP nanoparticle. However, the number of cavities in the MIP nanoparticle is not limited and may be one. One or more of the target molecules (original template material) may bind to the MIP nanoparticle.

[0017] Further, the emulsion polymerization process is advantageous in controlling particle size and yielding nanoparticles with a smaller size. A smaller size can enhance the interaction between the MIP nanoparticles and the selected target, improving sensitivity.

[0018] 1) Emulsion polymerization process The present method includes subjecting a functional monomer, a stimulus-responsive monomer, and a crosslinker to an emulsion polymerization process in the presence of a template material. The polymerization typically proceeds in an oil-in-water emulsion.

[0019] a) Template material The template material is not particularly limited and may be a biological receptor, nucleic acid, cell, spore, virus, microorganism, tissue sample, carbohydrate, oligosaccharide, polysaccharide, peptide, nucleoprotein, mucoprotein, lipoprotein, synthetic protein, glycoprotein, glycosaminoglycan, steroid, hormone, immunosuppressant, heparin, antibiotic, vitamin, biomarker of a pathological or disease state, toxin, pesticide, herbicide, explosive, nerve agent, pollutant, endocrine disrupting compound, nucleotide, nucleoside, oligonucleotide, metabolite, secondary metabolite, drug metabolite, drug intermediate or drug or other class of template known to those skilled in the art.

[0020] Examples of the template material include propranolol, vasolan, pentamidine, theophylline, caffeine, morphine, atenolol, paracetamol, ibuprofen, naproxen, sameridinum, pentamidine, verapamil, tramadol, dopamine, methylsameridinum, amobarbital, alfuzosin, zidovudine, stavudine, bupivacaine, mepivacaine, ropivacaine, neurosedyn, lamotrigine, monosulfuron, nicotine, taxol, vitamin B, vitamin B2, ephedrine, phenylalanine aniline, phenytoin, diazepam, clenbuterol, bromoclenbuterol, bisphenol A, p-tert-butylphenol, p-nitrophenol, parachlorophenol, benzopyrene, diphenyl phosphate, metsulfuron methyl, monosulfuron, clenbuterol, 9-ethyl adenine, melamine, quercetin, penicillin, erythrocin, oxytetracycline, chloramphenicol, ochratoxin A, tetracycline, norfloxacin, fluoroquinolone, cefalexin, ciprofloxacin, enrofloxacin, ofloxacin, cefathiamidine, amoxicillin, carbamazepine, oxcarbazepine, trimethoprim, monothiophosphate, dithiophosphate, pyrophosphate, phosphamide, thiophosphoryl amide, N-methylcarbamate pesticide, dimethylamino carbamate, triazine, amidine, nereistoxin insecticides, ureas, dithiocarbamate, sulfamic acids, glucosinolates sulfonic acid esters, trichloromethylthio, pirimicarb, imidacloprid, atrazine, ametryn, alachlor, acetochlor, butachlor, metolachlor, prometryn, paraquat, quizalofop-p-ethyl, imazethapyr, fomesafen, clomazone, benazolin, amitraz, diazinon, acephate, deltamethrin, isoproturon, fenuron, linuron, metoxuron, chlortoluron, metobromuron, tebuconazole, 2-methyl-4-chlorophenoxyacetic acid, 2,4-dichlorophenoxyacetic acid (2,4-D), 2,4,5-trichlorophenoxy acetic acid, simazine, propazine, terbuthylazine, estradiol, ethinyl estradiol, 17-β-estradiol, testosterone, testosterone glucoside acid, cortisone acetate, dexamethasone acetate, dermhealth cream, enfu cream, compound ketoconazole cream, compound ketone cream, triamcinolone cream, halcinonide solution, ketoconazole, elosone, hydrocortisone butyrate, sicorten, sicorten plus, clobetasol propionate, sokhan, iprobenfos, dexamethasone sodium phosphate, cortisone, hydrocortisone, hydrocortisone acetate, hydrocortisone butyrate, dexamethasone, dexamethasone acetate, prednisone, double beclomethasone propionate, mometasone furoate, fluocinolone acetonide, betamethasone dipropionate, halometasone monohydrate, beclomethasone, betamethasone 21-acetate, prednisolone, tobradex, fluorometholone, triamcinolone, halcinonide, clobetasol propionate. Polyfluoroalkyl substances (PFAS) including perfluorooctanoic acid (PFOA) and perfluorooctanesulfonate (PFOS) may be used as the template material.

[0021] The template material is used basically alone, however, two or more may be used.

[0022] b) Functional monomer The functional monomer is a compound having an ethylenically unsaturated group and a functional group capable of interacting with the template material. The functional monomer allows for specific binding to the template material.

[0023] The interaction between the functional group and the template material is not particularly limited as long as it is not a covalent-boding, and includes hydrogen bonding, metal coordination, hydrophobic forces, van der Waals forces, or electrostatic forces.

[0024] The functional group may be selected according to the template material and the interaction, and examples of the functional group include alkoxycarbonyl, carboxy, amide, amino, hydroxy, imidazolyl, thiol, pyrrolyl, pyridinyl, pyridyl, isocyanato, cyanato, isocyanurate group, boronate group. The residue of nucleosides, carbohydrates, etc. may also be used.

[0025] Examples of the functional monomer include: a (meth)acrylic acid, a (meth)acrylate, a (meth)acrylamide (e.g. acrylamide, methacrylamide, N-(hydroxymethyl)acrylamide (NHMAm), N-isopropyl acrylamide (NiPAm)). The functional monomer may be an amine compound, an alcohol compound, a phenolic compound, a carboxylic acid compound, a imidazole compound, a thiol compound, a pyrrole compound, a pyridine compound, an isocyanate compound, a cyanate compound, an isocyanurate compound, a boronic acid compound, a nucleoside, and a carbohydrate.

[0026] The functional monomer may be used alone or two or more functional monomers in combination.

[0027] c) Stimulus-responsive monomer The stimulus-responsive monomer is a compound that is reactive to a predetermined stimulus and imparts reactivity to a copolymer containing a unit derived from this monomer to a predetermined stimulus. The stimulus-responsive monomer also has an ethylenically unsaturated group, and forms the MIP polymer matrix together with the functional monomer through the emulsion polymerization.

[0028] The stimulus-responsive monomer may be responsive to temperature, pH, light, ionic strength, electric field, magnetic field or the presence of a specific chemical species.

[0029] The stimulus-responsive monomer may be a temperature-responsive monomer. As to the temperature-responsive monomer, a compound used as raw material for thermoresponsive polymeric material having lower critical solution temperature (LCST) may be mentioned. Examples of the temperature-responsive monomer include N-alkyl acrylamide (ex. N-ethyl acrylamide, N-isopropyl acrylamide, N-n-propyl acrylamide, N-n-butyl acrylamide, N-tert-butyl acrylamide), N-vinyl alkyl amide (ex, N-vinyl isopropyl amide, N-vinyl n-propyl amide, N-vinyl n-butyl amide, N-vinyl tert-butyl amide), polyalkylene glycol (meth)acrylate (ex, polyethylene glycol methacrylate, polyethylene glycol acrylate, polypropylene glycol methacrylate, polypropylene glycol acrylate, 2-(dimethylamino)ethyl methacrylate (DMAEMA), triethylene glycol dimethacrylate (TEGMA). Of these, N-isopropylacrylamide (NiPAm), polyethylene glycol methacrylate (PEGMA), 2-(dimethylamino)ethyl methacrylate (DMAEMA), and triethylene glycol dimethacrylate (TEGMA) are preferred.

[0030] The stimulus-responsive monomer may be a light-responsive monomer. As to the light-responsive monomer, a photochromic compound used as raw material for photoresponsive polymeric material may be mentioned. Examples of the light-responsive monomers include a compound having a chemical structure such as azobenzene, fulgide, indigo, diarylethene, spiropyran. A carboxyl group-containing compound, and an amino-containing compound, that are photoreactive and have an ethylenically unsaturated group may also be used.

[0031] The stimulus-responsive monomer may be a redox-responsive monomer, and examples include nitroxide, and disulfide.

[0032] The stimulus-responsive monomer is used basically alone, however, two or more may be used. In case two or more stimulus-responsive monomers are used, they may be reactive to the same stimulus. The functional monomer and the stimulus-responsive monomer that are subjected to the emulsion polymerization process are different from each other.

[0033] d) Crosslinker The crosslinker is a compound with two or more ethylenically unsaturated groups. Examples of the crosslinker include (meth)acrylate having two or more ethylenically unsaturated groups such as 1,2-ethanediol di(meth)acrylate, 1,3-propanediol di(meth)acrylate, 1,3-butanediol di(meth)acrylate, 1,4-butanediol di(meth)acrylate, 1,5-pentanediol di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, ethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, butylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, polypropylene glycol di(meth)acrylate, polybutylene glycol di(meth)acrylate, allyl (meth)acrylate; polyvinylbenzene such as divinylbenzene, trivinylbenzene; trialkylisocyanurate.

[0034] e) Label monomer (optional) A monomer having a labeling function (hereinafter, also referred to as “label monomer”) may be subjected to the emulsion polymerization process. The label monomer is a monomer that is incorporated into the MIP polymer matrix and provides a labeling function for identifying or quantifying the presence of the target molecule, without affecting binding.

[0035] The labeling function may be based on a fluorescent label, a colorimetric label, an electrochemical label, a magnetic label, a quantum dot or nanoparticle-based label, an optical sensor label, a photoacoustic label, a biological label or an enzyme-linked label.

[0036] Examples of the label monomer are as follows: Examples of fluorescent labels: - Fluorescein-based monomers - Rhodamine B-based monomers - coumarin-based monomers - Alexa Fluor (Registered Trademark)-based monomers Examples of colorimetric labels: - Azo-functionalized-based monomers - Phenolic-based monomers - Chromogenic dyes Examples of electrochemical labels: - Ferrocene-based monomers - Pyrrole and polypyrrole derivatives - Cobalt or nickel complexes Examples of magnetic labels: - Magnetic nanoparticle-conjugated monomers - Magnetic polymers Examples of quantum dots or nanoparticle-based labels - Quantum dot-conjugated monomers - Gold nanoparticles - Silver nanoparticles Examples of Optical Sensor labels: - Nile Red or BODIPY derivatives - Silane-based monomers Examples of Photoacoustic labels - Cyanine dyes (cy3, cy5, cy7, etc.) Examples of biological labels - Biotinylated monomers - Fluorescent protein labels (GFP) Examples of enzyme-linked labels - Horseradish peroxidase - Glucose oxidase

[0037] The label monomer may be used alone or two or more may be used in combination.

[0038] f) Solvent In the emulsion polymerization process, a hydrophobic organic solvent and water or a mixture of water and water-soluble organic solvent (hereinafter also referred to as “aqueous solvent”) are used as solvents. Emulsion polymerization may proceed in a water-in-oil emulsion in which aqueous solvent forms the continuous phase and the hydrophobic organic solvent forms the dispersed phase.

[0039] The hydrophobic organic solvent is not particularly limited as long as it is immiscible with water, and examples include hydrocarbons (for example, toluene, benzene, xylene, hexane, cyclohexane), chlorine-containing hydrocarbons (for example, methylene chloride, chloroform, chlorobenzene, etc.). The hydrophilic organic solvent may be used alone or two or more may be used in combination.

[0040] As to the aqueous solvent, water is preferred. For the water, purified water may be used, and ultrapure water is preferred. The water-soluble organic solvent is not particularly limited, and examples of the water-soluble organic solvent include alcohols such as methyl alcohol, ethanol, n-propyl alcohol, isopropyl alcohol, t-butyl alcohol, and benzyl alcohol, and nitrogen-containing organic solvents such as N-methyl pyrrolidone. The water-soluble organic solvent used is preferably a solvent which is immiscible with the hydrophobic organic solvent. The water-soluble organic solvent may be used alone or two or more may be used in combination.

[0041] g) Initiator (optional) In the emulsion polymerization process, an initiator is preferably used to initiate the polymerization. The initiator is not particularly limited, and is preferably a free-radical initiator. Examples of the free-radical initiator include an azo type free radical initiator, peroxide type free radical initiator, redox type initiator. Examples of the azo type free radical initiator include 2,2'-azobisisobutyronitrile (AIBN), 2,2'-azobisisoheptonitrile, 2,2'-azobis(2-cyano-2-butane), 2,2-azobis(methyl isobutyrate), 4,4'-azobis(4-cyanovaleric acid), 4,4'-azobis(4-cyano-1-pentanol), 1,1'-azobis(cyano cyclohexane),2-tert-butylazo-2-cyanopropane, 2,2'-azo-bis{2-methyl-N- [1,1-bis(hydroxymethyl)-2-hydroxyethyl] propionamide}, 2,2'-azobis[(2-methyl-N- hydroxyethyl) propionamide], bihydrochloride 2,2'-azobis(N,N'-bimethylene isobutyl amy), bihydrochloride 2,2'-azobis ( 2 3 ) the molar percentage of the small chain transfer agent amidinopropane), 2,2'- azobis (N,N'-bimethylene isobutylamine), 2,2'-azobis{2-methyl-N-[1,1-bis(hydroxymethyl)-2-hydroxyethyl] propionamide), 2,2'-azobis{2-methyl-N-[1,1-bis(hydroxymethyl)ethyl) propionamide), 2,2'-azobis[2-methyl -N-(2-hydroxyethyl) propionamide], dihydrate 2,2'-azobis(isobutyramide), 2,2'-azobis (2,2,4-trimethylpentane), 2,2'-azobis(2-methylpropane). Examples of peroxide type free radical initiator include tert-butyl hydroperoxide, cumene hydroperoxide, benzoyl peroxide, lauroyl peroxide, p-menthane hydroperoxide, and diisopropyl benzene hydroperoxide. Examples of redox type initiator include combination of persulfate and sodium hydrogen sulfite or combination of peracid and sodium ascorbate.

[0042] h) Emulsifier (optional) In the emulsion polymerization process, an emulsifier may be used for emulsification. The emulsifier is preferably a surfactant. The surfactant is not particularly limited, and may be an anionic, cationic nonionic, amphoteric or polymeric surfactant. Examples of anionic surfactants include polyoxyalkylene alkyl ether sulfates, sodium polyoxyalkylene oleyl ether sulfates, polyoxyalkylene alkyl phenyl ether sulfates, alkyl diphenyl ether disulfonates salts, polyoxyalkylene (mono, di, tri) styrylphenyl ether sulfates, polyoxyalkylene (mono, di, tri) benzylphenyl ether sulfates, alkenyl succinate di-salts; sodium dodecyl sulfate, potassium dodecyl sulfate, alkyl sulfate salts such as ammonium alkyl sulfate; sodium dodecyl polyglycol ether sulfate; sodium sulfuricinoate; alkyl sulfonates such as sulfonated paraffin salts; sodium dodecyl benzene sulfonate, alkyl sulfonates such as alkali metal sulfates of alkali phenol hydroxyethylene; high alkyl naphthalene sulfonates; naphthalene sulfonate formalin condensates; fatty acid salts such as sodium laurate, triethanolamine oleate, triethanolamine abietate; polyoxyalkyl ether sulfates; polyoxyethylene carboxylate sulfates; polyoxyethylene phenyl ether sulfates; succinate dialkyl ester sulfonates; polyoxyethylene alkylarylsulfates, etc. Examples of cationic surfactants include dialkyldimethylammonium salts, ester-type dialkylammonium salts, amide-type dialkylammonium salts, and dialkylimidazolinium salts. Examples of the nonionic surfactants include polyoxyethylene alkyl ethers; polyoxyethylene alkyl aryl ethers; sorbitan aliphatic esters; polyoxyethylene sorbitan aliphatic esters; aliphatic monoglycerides such as monolaurate of glycerol; polyoxyethylene oxypropylene copolymers; condensation products of ethylene oxide with aliphatic amines, amides or acids. Examples of amphoteric surfactants include alkyl dimethyl amino acetate betaine, alkyl dimethyl amine oxide, alkyl carboxymethyl hydroxyethyl imidazolinium betaine, alkyl amidopropyl betaine, alkyl hydroxysulfobetaine, etc. Examples of polymeric surfactants include polyvinyl alcohol and its modified products; (meth)acrylic water-soluble polymers; hydroxyethyl (meth)acrylic water-soluble polymers; hydroxypropyl (meth)acrylic water-soluble polymers; and polyvinylpyrrolidone, etc.

[0043] i) Other components (optional) The emulsion polymerization process may be performed in the presence of other components such as polymerization accelerators, dispersants, and chain transfer agents.

[0044] j) Amount of each component In the emulsion polymerization process, essential and optional components can be used, for example, in the following amounts.

[0045] The amount of the template material may be 0.02 mol or more, preferably 0.05 mol or more, and may be 0.50 mol or less, preferably 0.25 mol or less, per total of one mol of the functional monomer and the stimulus-responsive monomer. This range is preferred in terms of high affinity for a selected target.

[0046] The amount of the stimulus-responsive monomer may be 0.2 mol or more, preferable 0.4 mol or more, and 8.0 mol or less, preferably 4.0 mol or less, per one mol of the functional monomer. This range is preferred in terms of high affinity for a selected target.

[0047] The amount of the crosslinker may be 2 mol or more, preferably 4 mol or more, and may be 10 mol or less, preferably 8 mol or less, per total of one mol of the functional monomer and the stimulus-responsive monomer. This range is preferred in terms of high affinity for a selected target.

[0048] When the label monomer is used, the amount of the label monomer may be 0.001 mol or more, preferably 0.005 mol or more, and 0.100 mol or less, preferably 0.050 mol or less, per total of one mol of the functional monomer and the stimulus-responsive monomer.

[0049] The solvent may be 200 parts by mass or more, preferably 400 parts by mass or more, and may be 10000 parts by mass or less, preferably 8000 parts by mass parts or less based on total 100 parts by mass of the functional monomer, the stimulus-responsive monomer and the crosslinker. This range is preferred to obtain the MIP nanoparticles with high affinity for a selected target.

[0050] The mass ratio of the hydrophobic organic solvent to the aqueous solvent (the hydrophobic organic solvent: the aqueous solvent) may be from 1.0:0.8 to 1.0:2.0, preferably from 1.0:1.0 to 1.0:1.5.

[0051] When the initiator is used, the amount of the initiator may be 0.1 mol or more, preferably 0.12 mol or more, and 0.2 mol or less, preferably 0.15 mol or less, per total of one mol of the functional monomer and the stimulus-responsive monomer.

[0052] When the emulsifier is used, the amount of the emulsifier may be 0.1 wt% or more, and 10 wt% or less, relative to the total amount of the functional monomer and the stimulus-responsive monomer.

[0053] The components used in the emulsion polymerization process are preferably a combination where the functional monomer is selected from a (meth)acrylic acid, and (meth)acrylamide compound, the stimulus-responsive monomer is a temperature-responsive monomer, and the crosslinker is a di(meth)acrylate compound, provided that the functional monomer and the stimulus-responsive monomer are different from each other. For example, when N-isopropylacrylamide (NiPAm) is used as a stimulus-responsive monomer, the (meth)acrylamide compound used as the functional monomer is selected from those other than NiPAm.

[0054] k) Emulsification In emulsion polymerization, the template material, the functional monomer, the stimulus-monomer, the crosslinker, the solvent, and an optional agent including initiator and emulsifier, are mixed.

[0055] It is preferable to pre-mix the template material and the functional monomers in the hydrophobic organic solvent among the solvent to form a complex of the template material and the functional monomer. The complex is advantageous in forming the desired cavity in the MIP nanoparticle. In addition to the template material and functional monomer, the stimulus-responsive monomer is preferably pre-mixed in the hydrophobic organic solvent.

[0056] The premixed mixture of the template material, the functional monomers and the stimulus-monomer in the hydrophobic organic solvent may be mixed with an aqueous solution of the aqueous solvent and the optional emulsifier, the cross-linker, and an optional component including the initiator. These may be mixed at once or sequentially. It is preferred that the components other than the initiator may be mixed and the initiator added last. When the initiator is used, the initiator may be added after emulsification and before polymerization.

[0057] The mixture is then stirred to form an emulsion which is typically an oil-in-water emulsion. Stirring may be performed by a stirring device. The stirring device is not particularly limited, and examples include ultrasonic homogenizers, high-pressure homogenizers. The conditions of the stirring are not particularly limited, and may be selected as appropriate to achieve the emulsion with desired particle size.

[0058] l) Polymerization The emulsion obtained is then heated to undergo polymerization. Prior to polymerization, a polymerization vessel is preferably degassed by nitrogen. Heating is preferably carried out under stirring. The conditions for polymerization are not particularly limited, and may be selected according to the monomers (the functional monomer, the stimulus monomer and the optional label monomer), the crosslinker. The heating temperature may be 40°C or higher and 80°C or lower, and the heating time may be 1 hour or more and 100 hours or less, preferably 4 hours or more and 16 hours or less. The polymerization can be performed under atmospheric pressure or under high pressure, for example, 0.1 MPa or more and 1.2 MPa or less. The polymerization under high pressure is advantageous in obtaining nanoparticles with smaller particle size.

[0059] 2) Process of releasing the template material In this process, the template material is released from a reaction product of the emulsion polymerization process by applying a corresponding stimulus to the stimulus-responsive monomer to obtain the MIP nanoparticles. It is assumed that the configuration of the portion derived from the stimulus-responsive monomer in the reaction product is changed by the corresponding stimulus, causing the template material to be removed. The template material is removed to leave behind a cavity within the MIP nanoparticle that is specific in shape, size and electrostatically specific to the template.

[0060] a) In cases in which a temperature-responsive monomer is used When the temperature-responsive monomer is used as the stimulus monomer, the corresponding stimulus is heat, and the template material can be released by heating the reaction product above the temperature at which the temperature-responsive monomer reacts. The reaction product may be heated after separating it from the reaction solution or it may be heated in the liquid state without separating it from the reaction solution.

[0061] The process of releasing the template material from the reaction product in emulsion state may also serve as the extraction process of the MIP nanoparticles. The template material may be released by heat to remove the solvent or to extract the product in the emulsion. For example, the Soxhlet extraction method may be used for the extraction. The conditions may be selected as appropriate.

[0062] In cases in which the reaction product is heated after separating it from the emulsion, it may be heated in an appropriate solvent. The solvent and the conditions of heating may be selected as appropriate.

[0063] The reaction product from which the template material has been released may be collected and washed as appropriate to obtain the MIP nanoparticles.

[0064] For example, in case that NiPAm is used as a stimulus-responsive monomer, Soxhlet extraction preferably involves the continued reflux of an acidic solution (low pH. ex, methanol:AcOH solution), causing a hot (low pH) solution to collect and wash the template material from the MIP. Hydrogel polymers that contain NiPAm exhibit a lower critical solution temperature (LCST) close to 40°C. When the temperature rises above LCST, water (contained within the polymer) is expelled leading to a collapse of the cavities contained within the MIP. This collapse of cavities reduces the binding capacity of the MIP, forcing the removal of the template material.

[0065] b) In case a light-responsive monomer is used When the light-responsive monomer is used as the stimulus monomer, the corresponding stimulus is light, and the template material can be released by irradiating light having an appropriate wavelength. The reaction product may be irradiated with light after separating it from the reaction solution or it may be irradiated with light in the liquid state without separating it from the reaction solution.

[0066] The response of the reaction product to light irradiation varies depending on the structure (e.g., chromophore) of the light-responsive monomer being incorporated. For example, in case that azobenzene is used as a light-responsive monomer, it may be mentioned as follows. Azobenzene can undergo photoinduced isomerization by switching from cis and trans conformations as a direct response to light stimuli. The inclusion of these molecules as photoactive monomers into the MIP results in photoinduced isomerization capabilities. This isomerization, results in a change in cavity shape and size, thus reducing the binding capacity and releasing the template material.

[0067] The reaction product from which the template material has been released may be collected and washed as appropriate to obtain the MIP nanoparticles.

[0068] c) In case a redox-responsive monomer is used When the redox-responsive monomer is used as the stimulus monomer, the template material can be released by an electrochemical stimulus. For example, electric current may be passed through the reaction solution to undergo redox reaction at the portion where the redox-responsive monomer being incorporated. This changes the selectivity, thus binding capacity of the cavity, releasing the template / target material.

[0069] The reaction product from which the template material has been released may be collected and washed as appropriate to obtain the MIP nanoparticles.

[0070] 2. Molecularly imprinted polymer nanoparticles The MIP nanoparticles obtained by the method described above are small in size and may have an average particle size determined by dynamic light scattering (DLS) of 60 nm or less. The present disclosure also relates to MIP nanoparticles, wherein the nanoparticles have an average particle size determined by DLS of 60 nm or less. Further, the present MIP nanoparticles according to the present disclosure preferably have the average particle size determined by DLS of 10 nm or more and 60 nm or less, more preferably 20 nm or more and 60 nm or less, and further more preferably 40 nm or more, and 60 nm or less.

[0071] The present MIP nanoparticles preferably satisfy the ratio of nanoparticles with a diameter of 40 nm to less than 60 nm of more than 90%.

[0072] The conditions of the DLS measurement are as described in the examples below, and size distribution is based on scattering intensity. The average particle size corresponds to the intensity-weighted average calculated by the following formula: Σ(differential intensity*particle size) / Σ(differential intensity)

[0073] The present MIP nanoparticles may comprise a copolymer of a functional monomer, a stimulus-responsive monomer, a cross-linker and optionally a monomer having a labeling function. With respect to the functional monomer, the stimulus-responsive monomer, the cross-linker and the monomer having a labeling function, the details including examples, preferences and amounts described in relation to the present method may be applied.

[0074] According to the present MIP nanoparticles, each MIP nanoparticle may have one or more cavities. The cavity (cavities) is specific in shape, size and electrostatically specific to the template material used in the production, and provides an affinity for the selected target.

[0075] With respect to the template material, the description including examples, preferences and amounts described in relation to the present method may be applied. The template material may be selected depending on the selected target.

[0076] 3. Component The present MIP nanoparticles may be immobilized on a carrier and used for various applications. The present disclosure also relates to a component comprising the present MIP nanoparticles immobilized on a carrier. The carrier may be selected according to the specific application of the carrier, for example, disposable sensor chips to detect target molecules.

[0077] 1) Immobilization 1 The present MIP nanoparticles may be immobilized with thin film. In this method, the present MIP nanoparticles are put on solid surface (e.g., a chip) and polymerized in a thin film to immobilize MIP nanoparticles on the surface. For example, the methods described in the following literature may be mentioned. Subrayal M. Reddy, et al., “Magnetic nanoparticle-facilitated rapid mass production of high affinity polymeric materials (nanoMIPs) for protein recognition and biosensing”, Biomater. Sci., 2024, 12, 5845-5855

[0078] 2) Immobilization 2 The present MIP nanoparticles may be immobilized with a functionalized surface. The process of this method is, for example, as follows: - Functionalizing the surface of the carrier (e.g., a chip having a surface that is gold, silver, or other metals) with molecules with thiol and carboxyl functions, and forming a covalent bond between the thiol functions and the surface. - Preparing the present MIP nanoparticles having functional groups (e.g., amino groups). - Applying the present MIP nanoparticles on the surface to form a covalent bond between the activated functional groups of the present MIP nanoparticles and carboxyl functions on the surface of the carrier. Instead of thiol and carboxyl groups, different functional groups may be used. In this case, at least one functional group forms a covalent bond with the surface of the carrier, while the other forms a covalent bond with the activated functional group of the present MIP nanoparticles.

[0079] 3) Immobilization 3 The present MIP nanoparticles may be immobilized by metal-polyphenol network (MPN). For example, the present MIP nanoparticles may be encapsulated within the MPN, or may be bound to the MPN surface.

[0080] 4. Application The present MIP nanoparticles may be used, for example, in the following applications: biosensing and diagnostics; drug delivery systems; chemical and food analysis; immunoassays and molecular recognition; separation and purification; tissue engineering and regenerative medicine; food and beverage industry; vaccines and immunotherapy; smart materials and sensors, etc.

[0081] The present disclosure also relates to a device comprising the present component. Examples of the device include a sensor, an analyzer, a separation device.Examples

[0082] The following provides more specific descriptions of the present invention based on certain examples.

[0083] The chemicals used in the examples are as follows.

[0084] Functional monomer:

[0085] Temperature-responsive monomer:

[0086] Crosslinker:

[0087] Label monomer:

[0088] Initiator:

[0089] <Example 1> (Molecularly imprinted nanoparticles Synthesis) The polymers were synthesized using an emulsion polymerization. A solution of the template, hydrocortisone (0.5 mmol, 181 mg) and monomers, NiPAm (2 mmol, 226 mg), NHMAm (1 mmol, 101 mg), AAm (1 mmol, 71 mg), AAc (0.3 mmol, 22 μL) in 20 mL chloroform was prepared and stirred for 60 minutes, to allow the monomers to pre-assemble around the template. A separate solution polyvinyl alcohol (PVA, n=approx. 1700) (20mg) in MilliQ water (25 mL) was prepared with stirring and gentle heating to ensure homogeneity. Upon cooling to room temperature, this solution was added to the monomer-template complex mixture, along with the crosslinker EGDMA (20 mmol, 3.96 g) and initiator AIBN (20 mg). The polymerization solution was then stirred and degassed with nitrogen for 10 minutes, before being placed in a water bath at 60 °C for 24 hours. The resultant MIP nanoparticles were then collected and washed using a Soxhlet extraction for 24 hours with a 9:1 solution of methanol: acetic acid, removing the template from the polymer. After template extraction, the obtained MIP nanoparticles were then rinsed with methanol (5 times) and dried overnight at 60 °C.

[0090] (Immobilization of MIP nanoparticles onto the surface plasmon resonance (SPR sensor surface)) A carboxymethyl dextran hydrogel coated gold CM5 sensor chip (Cytival, Japan) was preconditioned with a phosphate-buffered saline (PBS) (at pH 7) and 0.01 % Tween 20 running buffer (referred to as PBST) at 10 μL min-1within the SPR. A 1 mL aqueous solution containing 40 mg 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and 10 mg N-hydroxysuccinimide (NHS) was passed over the chip (6 minutes at 10 μL min-1). The MIP nanoparticles (approximately 400 μg) were dissolved in 1 mL PBST solution containing sodium acetate (10 mM), activating amine groups. This mixture was then added over the activated working channel of the chip for 1 minute. The activated amine groups contained within the polymeric MIP nanoparticle matrix, react with the functionalized surface of the chip leading to a covalent attachment of the MIP nanoparticles to the surface. A solution of ethanolamine (1 M at pH 8.5) was then injected over the working and reference channels for 8 minutes, to quench any remaining activated groups. A continuous flow of PBST at 10 μL min-1is then maintained after the completion of the MIP nanoparticle immobilization. SPR kinetic assays are then carried out after a stable baseline is achieved.

[0091] (Kinetic Analysis using SPR) The binding affinity of the MIP nanoparticles was investigated through SPR binding kinetic analysis, and was performed using a 2 minute association (PBST with analyte concentrations of 0, 4, 8, 16, 32, 64 nM), followed by a 5 minute dissociation (PBST), then a regeneration cycle (using a 10 mM Glycine-HCl at pH 2 solution) for 1 minute and a final stabilization cycle of PBST for 1 minute). The initial (0 nM) injection was used in the first run as a blank PBST control with increasing analyte concentration for subsequent runs. After analyses were complete, the reference channel was subtracted from the working channel. The analyte was hydrocortisone for determining KD value (target) and cholesterol for determining KD value (non-target). The SPR responses were fitted using a 1:1 Langmuir bio-interaction (BI) model utilizing Biacore evaluation software. The association rate constants (ka), dissociation rate constants (kd), and maximum binding (Bmax) were fitted globally, while the BI signal is fitted locally. This enables the calculation of the equilibrium dissociation constants (KD) where KD= kd / ka.

[0092] (Particle size) Particle size (effective hydrodynamic diameters) is measured using dynamic light scattering (DLS), at 25 °C, in water. Measurements obtained are via intensity of scattered light, and the average particle corresponds to the average particle size corresponds to the intensity-weighted average calculated by the following formula: Σ(differential intensity*particle size) / Σ(differential intensity) The instrument used for the measurements was Otsuka Electronics Co., Ltd. ELSZ-2000. The sample was prepared by dissolving the sample (approximately 100 μg mL-1), minimum of 2 mL sample, in MilliQ water and vortexed for 5 minutes. The sample was analyzed in a glass cuvette, at 25 °C, with 5 repeats. Although the average particle sizes measured with DLS in Examples synthesized under atmospheric pressure were 40 nm or larger and 60 nm or smaller, it is possible to synthesize MIP nanoparticles smaller than 40 nm as well, for example, by applying higher pressure during synthesis. Figure 3 shows a chart regarding the cumulative distribution curve of the MIP nanoparticles obtained in Example 1.

[0093] <Examples 2-3 and Comparative example 1> For Examples 2-3 and Comparative Example 1, the experiments were conducted in the same manner as in Example 1, except that the monomers used and their ratios were changed to those shown in Table 1.

[0094] <Example 4> For Example 4, the experiment was conducted in the same manner as in Example 1, except that the template material was changed to ciprofloxacin. As for the Kinetic Analysis using SPR, the analyte was ciprofloxacin for determining KD value (target) and moxifloxacin for determining KD value (non-target).

[0095] <Comparative Example 2> For Comparative Example 2, the experiment was conducted in the same manner as in Example 1, except that the monomers used and their ratios were changed to those shown in Table 1, and that the template material was changed to andarine. As for the Kinetic Analysis using SPR, the analyte was andarine for determining KD value (target) and moxifloxacin for determining KD value (non-target). The experiment was conducted with reference to the following paper: Mark V. Sullivan et al, “A rapid synthesis of molecularly imprinted polymer nanoparticles for the extraction of performance enhancing drugs (PIEDs)”, Nanoscale Adv., 2023, 5, 5352-5360

[0096] <Comparative Example 3> Comparative Example 3 is an example of MIP prepared by the conventional solid-phase method. The experiment was conducted with reference to the following paper: Mark V. Sullivan, et al. “polymer nanoparticle-based surface plasmon resonance sensor platform for antibiotic detection in river water and milk”, Analytical and Bioanalytical Chemistry, Volume 414, pages 3687-3696, (2022)

[0097] The compositions and molar ratio are as follows: Monomers: AAc: 5 NiPAm: 27 N-tert-butylacrylamide (TBAm): 12 N-(3-Aminopropyl)methacrylamide hydrochloride (NAPAm): 6 Crosslinker: N,N'-Methylenebisacrylamide (BIS): 1 Template material Ciprofloxacin: 4

[0098] As for the Kinetic Analysis using SPR, the analyte was ciprofloxacin for determining KD value (target) and moxifloxacin for determining KD value (non-target).

[0099]

[0100] <Application examples> A biosensor was fabricated using the MIP nanoparticles according to Example 1 as follows: Onto a Carboxylic Acid pre-functionalized Gold on Copper electrode (available from Nutrix), activated with 1-Ethyl-3-(3-methylaminopropyl)carbodiimide hydrochloride (EDC - 40 mg mL-1) and N-Hydroxy succinimide (NHS - 10 mg mL-1), 100μl of a solution containing MIP nanoparticles of Example 1 at concentration 1 mg mL-1in solvent (acetonitrile) was pipetted onto the electrode, allowed to stand for 60 minutes and then rinsed with water to obtain biosensor.

[0101] EIS measurements were performed on cortisol and cholesterol samples at varying concentrations to investigate selectivity of the biosensor. (A) target molecule Cortisol (B) non-target Cholesterol.

[0102] EIS measurements were conducted by adding 100μl of Redox solution (0.5 M KCl and 5 mM potassium ferricyanide) under the condition of the frequency range of 100 kHz to 0.1Hz at Eac of 0.02 V and Edc of + 0.23 V to calculate ΔRct through fitting of Randle Circuit. The results are shown in Figure 2.

[0103] As shown in Figure 2, there is a significant decrease in selectivity towards Cholesterol, which indicates the excellent performance of this biosensor against other similar structured molecules.

[0104] According to the present disclosure, an inexpensive method of producing molecularly imprinted polymer nanoparticles with a smaller size and high affinity for a selected target is provided.

Claims

1. A method for producing molecularly imprinted polymer nanoparticles, comprising: subjecting a functional monomer, a stimulus-responsive monomer, and a crosslinker to an emulsion polymerization process in the presence of a template material and optionally an initiator; and releasing the template material from a reaction product of the emulsion polymerization process by applying a corresponding stimulus to the stimulus-responsive monomer to obtain the molecularly imprinted polymer nanoparticles.

2. The method for producing molecularly imprinted polymer nanoparticles according to claim 1, wherein the emulsion polymerization process includes mixing and stirring a premixed mixture containing the template material, the functional monomer, the stimulus-responsive monomer and a hydrophobic organic solvent; an aqueous solution containing an aqueous solvent and optionally an emulsifier; the crosslinker; and optionally the initiator.

3. The method for producing molecularly imprinted polymer nanoparticles according to claim 1 or 2, wherein the functional monomer is capable of interacting with the template material by hydrogen bonding, metal coordination, hydrophobic forces, van der Waals forces, or electrostatic forces.

4. The method for producing molecularly imprinted polymer nanoparticles according to any one of claims 1 to 3, wherein the functional monomer is selected from the group consisting of a (meth)acrylate, a (meth)acrylamide, an amine compound, an alcohol compound, a phenolic compound, a carboxylic acid compound, a imidazole compound, a thiol compound, a pyrrole compound, a pyridine compound, an isocyanate compound, a cyanate compound, an isocyanurate compound, a boronic acid compound, a nucleoside, and a carbohydrate.

5. The method for producing molecularly imprinted polymer nanoparticles according to any one of claims 1 to 4, wherein the stimulus-responsive monomer is responsive to temperature, pH, light, ionic strength, electric field, magnetic field or the presence of a specific chemical species.

6. The method for producing molecularly imprinted polymer nanoparticles according to any one of claims 1 to 5, wherein the stimulus-responsive monomer is a temperature-responsive monomer selected from the group consisting of N-isopropylacrylamide (NiPAm), polyethylene glycol methacrylate (PEGMA), 2-(dimethylamino)ethyl methacrylate (DMAEMA), and triethylene glycol dimethacrylate (TEGMA).

7. The method for producing molecularly imprinted polymer nanoparticles according to any one of claims 1 to 6, wherein the crosslinker is selected from the group consisting of 1,2-ethanediol di(meth)acrylate, 1,3-propanediol di(meth)acrylate, 1,3-butanediol di(meth)acrylate, 1,4-butanediol di(meth)acrylate, 1,5-pentanediol di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, ethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, butylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, polypropylene glycol di(meth)acrylate, polybutylene glycol di(meth)acrylate, allyl (meth)acrylate, divinylbenzene, trivinylbenzene, and trialkylisocyanurate.

8. The method for producing molecularly imprinted polymer nanoparticles according to any one of claims 1 to 7, wherein the amount of the crosslinker is 2 mol or more, and 10 mol or less, per total of one mol of the functional monomer and the stimulus-responsive monomer.

9. The method for producing molecularly imprinted polymer nanoparticles according to any one of claims 1 to 8, further comprising subjecting a monomer having a labeling function to the emulsion polymerization process.

10. The method for producing molecularly imprinted polymer nanoparticles according to claim 9, wherein the labeling function is based on a fluorescent label, a colorimetric label, an electrochemical label, a magnetic label, a quantum dot or nanoparticle-based label, an optical sensor label, a photoacoustic label, a biological label or an enzyme-linked label.

11. The method for producing molecularly imprinted polymer nanoparticles according to any one of claims 1 to 10, wherein the template material is selected from the group consisting of biological receptor, nucleic acid, cell, spore, virus, microorganism, tissue sample, carbohydrate, oligosaccharide, polysaccharide, peptide, nucleoprotein, mucoprotein, lipoprotein, synthetic protein, glycoprotein, glycosaminoglycan, steroid, hormone, immunosuppressant, heparin, antibiotic, vitamin, biomarker of a pathological or disease state, toxin, pesticide, herbicide, explosive, nerve agent, pollutant, endocrine disrupting compound, nucleotide, nucleoside, oligonucleotide, metabolite, secondary metabolite, drug metabolite, drug intermediate, and drug.

12. A molecularly imprinted polymer nanoparticle, wherein the nanoparticle has an average particle size determined by dynamic light scattering of 60 nm or less.

13. The molecularly imprinted polymer nanoparticle according to claim 12, wherein the nanoparticle has an average particle size of 40 nm or more and 60 nm or less.

14. The molecularly imprinted polymer nanoparticle according to claim 12 or 13, wherein the ratio of nanoparticles with a diameter of 40 nm to less than 60 nm is more than 90%.

15. The molecularly imprinted polymer nanoparticle according to any one of claims 12 to 14, wherein the nanoparticle comprises a copolymer of a functional monomer, a stimulus-responsive monomer, a cross-linker and optionally a monomer having a labeling function, and has at least one cavity corresponding to a template material16. A component comprising a plurality of molecularly imprinted polymer nanoparticles according to any one of claims 12 to 15 immobilized on a carrier.

17. The component according to claim 16, wherein the carrier has a functional group on its surface and the plurality of molecularly imprinted polymer nanoparticles is immobilized on the carrier by forming a covalent bond between the functional group and a functional group of a unit derived from the functional monomer of the copolymer.

18. A device comprising the component according to claim 16 or 17.